ColorTokens
Leading Biotechnology Company Selects ColorTokens for Legacy Infrastructure Protection
Summary
A major biotechnology firm with over 10,000 employees partnered with ColorTokens to secure vulnerable legacy systems, meet regulatory compliance, and protect sensitive business and patient data. By im...
Value Drivers
Challenges
- Legacy systems (Windows XP, Windows 2003) vulnerable due to lack of security updates from the vendor
- Lack of real-time visibility into operations
- Difficulty in scaling current infrastructure
- High operational costs due to legacy systems
- Poor data integration across departments
4 more challenges available
Solutions
- Deployment of ColorTokens platform to legacy systems for zero-trust security and micro-segmentation
- Deployed real-time monitoring and analytics platform
- Migrated to cloud-based scalable infrastructure
- Modernized legacy systems with new technology stack
- Integrated data across all business functions
- Introduced AI-powered automation tools
5 more solutions available
Outcomes
- Proactively prevented 5 million unauthorized network connections
- Achieved 24/7 real-time visibility and monitoring
- Successfully scaled operations to support 3x growth
- Decreased operational costs by 40% annually
- Improved data accuracy and accessibility by 85%
- Automated 70% of manual processes
- Enhanced decision-making with unified analytics
6 more outcomes available
Products
Software
ColorTokens Platform
A comprehensive zero-trust cybersecurity platform enabling micro-segmentation, flow visibility, and policy enforcement across legacy and modern systems.
Sample Category
Sample Product 2
Sample product description for demonstration purposes.
1 more products available
Target Organization
unknown
Description: A leading biotechnology and development company focused on researching neurological diseases and enhancing quality of life for terminal patients.
Industry:Biotechnology, Pharmaceutical